Academic institutions like Roswell Park Comprehensive Cancer Center are significantly scaling in-house clinical-grade cell manufacturing facilities, enabling higher throughput and tighter integration with pharma industry partnerships. Roswell Park's newly expanded GMP cleanroom complex positions it as the largest academic cell therapy production site in the US, facilitating hundreds of patient treatments annually. The integration of industry experts into academic teams enhances the translation of therapies from discovery to clinical and regulatory milestones. This trend reflects an evolving ecosystem supporting personalized therapeutics development with streamlined capabilities.